Glossary/Medications

SGLT2 Inhibitor.

Sodium-glucose cotransporter 2 inhibitor. Originally developed for diabetes, these medications (empagliflozin, dapagliflozin) have shown significant benefits in heart failure, reducing hospitalizations and cardiovascular death regardless of diabetes status.

Definition

What is sglt2 inhibitor?

Sodium-glucose cotransporter 2 inhibitor. Originally developed for diabetes, these medications (empagliflozin, dapagliflozin) have shown significant benefits in heart failure, reducing hospitalizations and cardiovascular death regardless of diabetes status.

Related Terms

Related glossary terms.

Heart Failure
A chronic condition in which the heart cannot pump blood efficiently enough to meet the body's ne...
HFrEF
Heart Failure with Reduced Ejection Fraction (EF 40% or less). Previously called systolic heart f...
HFpEF
Heart Failure with Preserved Ejection Fraction (EF 50% or greater). Previously called diastolic h...
Diuretic
A medication that helps the kidneys remove excess fluid and salt from the body through urine. Use...
Previous
Septal Myectomy
Next
Shared Decision-Making
Browse all 200 terms
Stay informed.
Expert cardiac surgery insights from the WhiteGloveMD Heart Team, delivered to your inbox.
No spam. Unsubscribe anytime. HIPAA-compliant.

Have questions about sglt2 inhibitor?

Our Heart Team provides expert second opinions with plain-language explanations. 24-hour turnaround.

Start Your Review Browse Conditions